Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even ...
The global active pharmaceutical ingredients market size was worth USD 239.18 billion in 2024 and is expected to reach around USD 368.49 billion by 2033, with a noteworthy CAGR of 5.64% from 2023 to ...
The country is limited by its market size. Oman’s pharmaceutical sector is expected to grow moderately from $76m in 2024 to ...
The Active Pharmaceutical Ingredient (API) Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries ...
Pharmaceutical packaging plays a crucial role in ensuring the safety, integrity, and efficacy of medicines. It is not just ...
The Duchenne muscular dystrophy (DMD) landscape across the seven major markets (7MM) - the US, France, Germany, Italy, Spain, ...
India's Contract Research, Development, and Manufacturing Organization (CRDMO) industry is on a strong growth trajectory, ...
Korean firms pursue botulinum toxin market amid rising global demand Pharmaceutical companies capitalize on expanding ...